Market Tracker

04/20 5:15pm ET

Cardiome Pharma Corp (NASDAQ:CRME)

2.29
Delayed Data
As of Apr 20
 -0.05 / -2.14%
Today’s Change
1.29
Today|||52-Week Range
4.84
+47.74%
Year-to-Date
4 Mid-Cap Companies With Rising Debt and Sinking Revenue
Apr 20 / GuruFocus News - Paid Partner Content
4 Mid-Caps With Sinking Revenue and Rising Debt
Apr 19 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close2.34
Today’s open2.33
Day’s range2.27 - 2.33
Volume53,638
Average volume (3 months)149,425
Market cap$57.1M
Data as of 3:59pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+41.79%
Earnings growth (this year)-3.39%
Earnings growth (next 5 years)--
Revenue growth (last year)+20.78%
P/E ratioNM
Price/Sales2.80
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...0.000.00%
ARLZAralez Pharmaceutica...0.000.00%
ZYNEZynerba Pharmaceutic...+0.25+2.42%
NOVNNovan Inc0.000.00%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 14, 2018
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$25.3M
Annual profit (last year)-$19.6M
Net profit margin-77.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bill Hunter
Chief Operating Officer
Sheila M. Grant
Corporate headquarters
Vancouver, British Columbia

Forecasts